<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T03:59:45Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/33823" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/33823</identifier><datestamp>2026-10-15T07:07:47Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Krepinsky, Joan</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Bonifacio Proietto, S. Davide</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department">Medical Sciences (Blood and Cardiovascular)</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2026-10-14T18:30:09Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2026</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/11375/33823</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/25593</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Chronic kidney disease (CKD) affects an estimated 10% of the global population, with
tubulointerstitial fibrosis representing the common pathological endpoint across nearly all disease
etiologies. Proximal tubular epithelial cells (PTECs) are increasingly recognized as active drivers
of this process through the secretion of profibrotic cytokines, including Activin A and Activin B,
members of the TGF-β superfamily. While Activin A is an established profibrotic mediator,
emerging evidence implicates Activin B as a potentially sustained contributor to fibrosis, and
preliminary data from our lab suggested that PTEC-specific deletion of Inhba (Activin A) reduces
Activin B expression in a murine model of renal fibrosis. This thesis tested the hypothesis that
Activin A regulates Activin B expression through the transcription factor SOX9, and investigated
whether this axis mediates paracrine crosstalk between PTECs and fibroblasts. Using HK-2 cells
and a PTEC-specific Inhba knockout mouse model of unilateral ureteral obstruction (UUO),
Activin A activation (via recombinant drug), and Activin A inhibition (via siRNA knockdown and
neutralizing antibody), consistently and bidirectionally altered Activin B mRNA and protein
expression, establishing that Activin A acts upstream of Activin B. Activin A was also shown to be
both necessary, in vivo, and sufficient, in vitro, for nuclear SOX9 accumulation, a marker of its
transcriptionally active state. Dual immunofluorescence further revealed that SOX9-positive
PTECs were spatially associated with regions of enriched myofibroblast activation, and
conditioned medium from Activin A-treated PTECs induced SOX9 expression in fibroblasts in an
Activin B-dependent manner, though this latter effect did not reach statistical significance.
Together, these findings support a model in which Activin A drives SOX9-dependent Activin B
upregulation in PTECs, positioning this axis as a candidate mechanism of epithelial-fibroblast
crosstalk and a potential therapeutic target in CKD.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en</dim:field>
   <dim:field mdschema="dc" element="rights" lang="en">Attribution-NonCommercial-NoDerivs 2.5 Canada</dim:field>
   <dim:field mdschema="dc" element="rights" qualifier="uri">http://creativecommons.org/licenses/by-nc-nd/2.5/ca/</dim:field>
   <dim:field mdschema="dc" element="title">Activin A Promotes Activin B Upregulation Through SOX9 in Chronic Kidney Disease</dim:field>
   <dim:field mdschema="dc" element="type" lang="en">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">embargo</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>